SERB
Location
ILE DE FRANCE
Founded
1951-07-25
Website
Risk Signals
32 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SERB
Live alerts from global media, monitored by Business Radar
2023-03-15 (globenewswire.com)
New economic analysis of Voraxaze® (glucarpidase) in patients with delayed methotrexate
Model simulation shows cost of timely Voraxaze® use is offset by shorter hospital stays and associated with substantially improved clinical outcomes...
Read more